search
Back to results

Use of CBT-I in Individuals With a Concussion

Primary Purpose

Concussion, Mild

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
cognitive behavioral therapy for insomnia (CBT-I)
Sponsored by
University of Kansas Medical Center
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Concussion, Mild

Eligibility Criteria

18 Years - 64 Years (Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Aged 18 to 64 years old
  • At least 4 weeks since concussion injury
  • Self-report difficulty falling asleep, maintaining sleep, or waking up too early at least 3 nights per week since injury
  • Score ≥10 on the Insomnia Severity Index to indicate clinical insomnia.
  • Score ≥25 on the Mini-Mental State Examination (MMSE) questionnaire

Exclusion Criteria:

  • Known untreated sleep disorder (such as sleep apnea, restless leg syndrome, circadian rhythm disorder, hypersomnia, parasomnias)
  • Increased risk obstructive sleep apnea (STOP BANG Score ≥3)
  • Increased risk of restless leg syndrome on RLS-Diagnosis Index
  • Increased risk of circadian rhythm sleep-wake disorder (respond "Yes" to all circadian rhythm questions).
  • Increased risk of parasomnia (Respond "Yes" to all questions for night mere disorder OR respond "Yes" to all REM sleep arousal disorder: Sleep walking questions, OR responds " Yes" to all REM sleep arousal disorder: Sleep Terrors questions, OR respond "Yes" to all REM sleep behavior disorder questions.)
  • Active abuse or history (up to 2 years) of alcohol/ drug dependence as defined by the DSM-V criteria
  • Severe mental illness such as schizophrenia or bipolar disorder
  • Score of > 29 on the Beck Depression Inventory or indication of suicidality (response of "2" or "3"to item 9)
  • History of diagnosed nervous system disorder other than concussion (such as multiple sclerosis, Parkinson's Disease, Stroke)
  • Currently works nightshift

Sites / Locations

  • Catherine Siengsukon

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

CBT-I Initial Group

Wait List Group

Arm Description

The CBT-I Initial Group will start the CBT-I intervention immediately following baseline assessments. After re-assessment 1, participants in the CBT-I Initial Group will continue with typical activities while the WL group will receive the CBT-I intervention. After re-assessment 2, both groups continue typical activities. All participants will complete a third re-assessment 21 weeks after starting the study.

The WL will wait 6 weeks before starting the CBT-I intervention. After re-assessment 1, participants in the CBT-I Initial Group will continue with typical activities while the WL group will receive the CBT-I intervention. After re-assessment 2, both groups continue typical activities. All participants will complete a third re-assessment 21 weeks after starting the study.

Outcomes

Primary Outcome Measures

change in Insomnia Severity Index
7 questions each rated on a 0-4 scale. The range of scores on the ISI is 0-28
change in PSQI
Scores range from 0-21 with a higher score indicating a lower quality of sleep
change in Post-Concussion Symptom Scale
Severity of 22 concussion-related symptoms are assessed by a Likert scale 0-6. Participants will rate their symptoms from a "0" or no symptom to "6" extreme symptom. A score of 132 is the maximum someone can have indicating all symptoms are severe. 2. The number of post-concussion symptoms will be assessed by counting the number of symptoms that the participant identified as having a severity of "1" or higher on the PCSS. A score of a "1" indicates that the symptom is mild, but still noticeable.
change in Beck Anxiety Inventory
The tool consists of 21 items that are scored on a Likert scale of 1-3. Scores range from minimal anxiety (0-7), mild anxiety (8-15) moderate anxiety (16-25) and severe anxiety (<30).
change in Beck Depression Inventory
21 item questionnaire used to assess the severity of depression. Scores range from 1 to greater than 40.

Secondary Outcome Measures

change in Dysfunctional Beliefs About Sleep (DBAS)
30 item Likert-scale self-report questionnaire with 0 = "strongly disagree" to 10 = "strongly agree"; scores range from 0-300 and a higher score indicates more dysfunctional beliefs about sleep
change in Sleep Self-Efficacy
9 item self-report Likert-scale questionnaire; Scores range from 0-45 and a higher score indicates higher sleep self-efficacy
change in RU-SATED questionnaire
to 6 questions asking sleep regularity, subjective satisfaction, appropriate timing, adequate duration, high sleep efficiency, and sustained alertness during the day; Participants answer each question with "Rarely/ Never" (0), " Sometimes" (1), and "Usually/ Always" (2). There are ten points possible.
change in plasma neurofilament light (NfL)
blood marker of axonal damage
change in plasma pTau181
blood marker of tauopathy

Full Information

First Posted
March 9, 2021
Last Updated
March 14, 2023
Sponsor
University of Kansas Medical Center
search

1. Study Identification

Unique Protocol Identification Number
NCT04885205
Brief Title
Use of CBT-I in Individuals With a Concussion
Official Title
Use of Cognitive Behavioral Therapy for Insomnia in Individuals With a Concussion
Study Type
Interventional

2. Study Status

Record Verification Date
March 2023
Overall Recruitment Status
Completed
Study Start Date
April 30, 2021 (Actual)
Primary Completion Date
December 2, 2022 (Actual)
Study Completion Date
December 2, 2022 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University of Kansas Medical Center

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Sleep disturbances have been shown to contribute to poorer recovery from a concussion. Furthermore, sleep disturbances have been associated with more frequent and severe post-concussion symptoms including headache, vertigo, anxiety, depression, and decreased short term memory reducing quality of life and productivity at work or school. Additionally, recent research indicates that individuals with a concussion who have poor sleep quality have increased levels of Neurofilament light (NfL) and tau biomarkers indicating that there may still be axonal damage after weeks or months after the initial concussion injury. Post-concussion symptoms have been associated with higher levels of these biomarkers and there has been a report of higher levels of NfL and tau years following a concussion event. Cognitive behavioral therapy for insomnia (CBT-I) is an effective treatment for insomnia yet it remains unclear if this treatment method is effective in improving sleep outcomes, reducing concomitant post-concussion symptoms, and biomarkers of neural injury/risk in individuals post- concussion. The central hypothesis for this project is treating sleep disturbances will yield a clinically relevant reduction in concomitant post-concussion symptoms. The objective for the proposed study is to determine if CBT-I will reduce insomnia symptoms and improve concomitant post-concussion symptoms in individuals after concussion and if symptom improvements are maintained at 6-weeks and 12-weeks after CBT-I intervention.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Concussion, Mild

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
40 (Actual)

8. Arms, Groups, and Interventions

Arm Title
CBT-I Initial Group
Arm Type
Experimental
Arm Description
The CBT-I Initial Group will start the CBT-I intervention immediately following baseline assessments. After re-assessment 1, participants in the CBT-I Initial Group will continue with typical activities while the WL group will receive the CBT-I intervention. After re-assessment 2, both groups continue typical activities. All participants will complete a third re-assessment 21 weeks after starting the study.
Arm Title
Wait List Group
Arm Type
Active Comparator
Arm Description
The WL will wait 6 weeks before starting the CBT-I intervention. After re-assessment 1, participants in the CBT-I Initial Group will continue with typical activities while the WL group will receive the CBT-I intervention. After re-assessment 2, both groups continue typical activities. All participants will complete a third re-assessment 21 weeks after starting the study.
Intervention Type
Behavioral
Intervention Name(s)
cognitive behavioral therapy for insomnia (CBT-I)
Intervention Description
The CBT-I program is a 6-week, 1x/week, one-on-one program. The delivery of CBT-I will be done remotely over a secure teleconference service (Zoom) or phone. Participants will maintain a sleep diary during the course of the program to aid in tailoring the intervention. Each session lasts about 45-60min:
Primary Outcome Measure Information:
Title
change in Insomnia Severity Index
Description
7 questions each rated on a 0-4 scale. The range of scores on the ISI is 0-28
Time Frame
baseline to 21 weeks
Title
change in PSQI
Description
Scores range from 0-21 with a higher score indicating a lower quality of sleep
Time Frame
baseline to 21 weeks
Title
change in Post-Concussion Symptom Scale
Description
Severity of 22 concussion-related symptoms are assessed by a Likert scale 0-6. Participants will rate their symptoms from a "0" or no symptom to "6" extreme symptom. A score of 132 is the maximum someone can have indicating all symptoms are severe. 2. The number of post-concussion symptoms will be assessed by counting the number of symptoms that the participant identified as having a severity of "1" or higher on the PCSS. A score of a "1" indicates that the symptom is mild, but still noticeable.
Time Frame
baseline to 21 weeks
Title
change in Beck Anxiety Inventory
Description
The tool consists of 21 items that are scored on a Likert scale of 1-3. Scores range from minimal anxiety (0-7), mild anxiety (8-15) moderate anxiety (16-25) and severe anxiety (<30).
Time Frame
baseline to 21 weeks
Title
change in Beck Depression Inventory
Description
21 item questionnaire used to assess the severity of depression. Scores range from 1 to greater than 40.
Time Frame
baseline to 21 weeks
Secondary Outcome Measure Information:
Title
change in Dysfunctional Beliefs About Sleep (DBAS)
Description
30 item Likert-scale self-report questionnaire with 0 = "strongly disagree" to 10 = "strongly agree"; scores range from 0-300 and a higher score indicates more dysfunctional beliefs about sleep
Time Frame
baseline to 21 weeks
Title
change in Sleep Self-Efficacy
Description
9 item self-report Likert-scale questionnaire; Scores range from 0-45 and a higher score indicates higher sleep self-efficacy
Time Frame
baseline to 21 weeks
Title
change in RU-SATED questionnaire
Description
to 6 questions asking sleep regularity, subjective satisfaction, appropriate timing, adequate duration, high sleep efficiency, and sustained alertness during the day; Participants answer each question with "Rarely/ Never" (0), " Sometimes" (1), and "Usually/ Always" (2). There are ten points possible.
Time Frame
baseline to 21 weeks
Title
change in plasma neurofilament light (NfL)
Description
blood marker of axonal damage
Time Frame
baseline to 21 weeks
Title
change in plasma pTau181
Description
blood marker of tauopathy
Time Frame
baseline to 21 weeks

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
64 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Aged 18 to 64 years old At least 4 weeks since concussion injury Self-report difficulty falling asleep, maintaining sleep, or waking up too early at least 3 nights per week since injury Score ≥10 on the Insomnia Severity Index to indicate clinical insomnia. Score ≥25 on the Mini-Mental State Examination (MMSE) questionnaire Exclusion Criteria: Known untreated sleep disorder (such as sleep apnea, restless leg syndrome, circadian rhythm disorder, hypersomnia, parasomnias) Increased risk obstructive sleep apnea (STOP BANG Score ≥3) Increased risk of restless leg syndrome on RLS-Diagnosis Index Increased risk of circadian rhythm sleep-wake disorder (respond "Yes" to all circadian rhythm questions). Increased risk of parasomnia (Respond "Yes" to all questions for night mere disorder OR respond "Yes" to all REM sleep arousal disorder: Sleep walking questions, OR responds " Yes" to all REM sleep arousal disorder: Sleep Terrors questions, OR respond "Yes" to all REM sleep behavior disorder questions.) Active abuse or history (up to 2 years) of alcohol/ drug dependence as defined by the DSM-V criteria Severe mental illness such as schizophrenia or bipolar disorder Score of > 29 on the Beck Depression Inventory or indication of suicidality (response of "2" or "3"to item 9) History of diagnosed nervous system disorder other than concussion (such as multiple sclerosis, Parkinson's Disease, Stroke) Currently works nightshift
Facility Information:
Facility Name
Catherine Siengsukon
City
Kansas City
State/Province
Kansas
ZIP/Postal Code
66160
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
36149737
Citation
Ludwig R, Rippee M, D'Silva LJ, Radel J, Eakman AM, Morris J, Drerup M, Siengsukon C. Assessing Cognitive Behavioral Therapy for Insomnia to Improve Sleep Outcomes in Individuals With a Concussion: Protocol for a Delayed Randomized Controlled Trial. JMIR Res Protoc. 2022 Sep 23;11(9):e38608. doi: 10.2196/38608.
Results Reference
derived

Learn more about this trial

Use of CBT-I in Individuals With a Concussion

We'll reach out to this number within 24 hrs